Breast and Gynecologic Cancer

The Breast and Gynecologic Cancer Research Group conducts and fosters the development of research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and precursor conditions related to these cancers.

Read more About the Breast and Gynecologic Cancer Research Group.

Staff

Funding Opportunities

Grants

Clinical Trials

Publications

Cancer Prevention Clinical Trials Network (CP-CTNet)

Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.

Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Major medical research centers conduct systematic early clinical development of promising preventive agents.

US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)

Partnership Centers will focus on improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals.

The ASCUS/LSIL Triage Study for Cervical Cancer (ALTS)

ALTS was a clinical trial to find the best way to help women and their doctors decide what to do about the mildly abnormal and very common Pap test results known as ASCUS and LSIL.

Addressing a ‘Last Mile’ Problem in Cervical Cancer Screening

A presentation (PDF, 1.12 MB) from the 14th Joint Meeting of the NCI Board of Scientific Advisors (BSA) and the National Cancer Advisory Board (NCAB) - December 2-3, 2019 by Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.

News and Events

When Prenatal DNA Tests Point to Cancer
Date Posted: May 17, 2023

Time-Restricted Eating Research: 2020 PQ2 Grantee Perspectives on Lessons Learned, Gaps, and Opportunities
Date Posted: May 9, 2023

The Diverse Aspects of Uterine Serous Cancer
Date Posted: May 8, 2023

2023 “Investigators' and Site Coordinators' Opportunity for Research Excellence” (I-SCORE) HYBRID meeting
Date Posted: February 8, 2023

Research Highlights: Learning More about Breast Cancer Prevention in Primary Care Settings
Date Posted: November 28, 2022

Variation in tumor-associated immune profiles and colorectal cancer outcomes

Considerable variability in tumor-associated immune responses exists across racial/ethnic populations. These variations may explain part of the observed disparities in response to cancer therapies, particularly immunotherapy, and treatment outcomes. In colorectal cancer (CRC), the intensity and composition of tumor infiltrating lymphocytes (TIL) are established prognostic and predictive...